Divigel vs. Bijuve

See how Divigel and Bijuve compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Divigel is an estrogen-only gel, so women with a uterus typically need to add a separate progestogen, while Bijuve combines estradiol and progesterone in one capsule.

  • Both treat moderate to severe menopausal hot flashes, but Bijuve is approved only for women who still have a uterus.

  • Divigel offers four adjustable dose strengths for titration, while Bijuve comes in just two fixed combination doses.

Divigel vs. Bijuve Drug Summary

Divigel

Divigel is an estrogen hormone therapy applied as a topical gel once a day to treat moderate to severe hot flashes of menopause. It comes in four dose strengths, letting a clinician adjust the amount based on symptom response. Because it contains only estrogen, women with a uterus typically need to take a separate progestogen alongside it.

Bijuve

Bijuve is a combination hormone therapy capsule containing bioidentical estradiol and micronized progesterone, taken once a day by mouth to treat moderate to severe hot flashes of menopause. It is approved only for women who still have a uterus, since the progesterone component protects against endometrial overgrowth caused by estrogen. Bijuve comes in two fixed-dose strengths rather than a range of adjustable doses.

Divigel vs. Bijuve Side Effects

Divigel

Most common
breast tenderness (>5%)
metrorrhagia (>5%)
vaginal mycosis (>5%)
nasopharyngitis (>5%)

Bijuve

Most common
breast tenderness (up to 10.4%)
headache (up to 3.4%)
vaginal bleeding (up to 3.4%)
vaginal discharge (up to 3.4%)

Divigel vs. Bijuve Dosage

Divigel

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 g once daily At the start
Maximum dose 1.0 g once daily If needed
Dose changes 3 increases As tolerated

Bijuve

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg/100 mg once daily At the start
Maximum dose 1 mg/100 mg once daily If needed
Dose changes 1 increase As tolerated

Divigel vs. Bijuve Indications

Divigel

Divigel is FDA-approved to treat moderate to severe hot flashes caused by menopause. It is also used off-label for vaginal dryness and atrophy, and for gender-affirming hormone therapy. It is not approved for preventing heart disease or dementia.

  • FDA-approved for moderate to severe menopausal hot flashes

  • Off-label use for vaginal dryness or atrophy

  • Off-label use in gender-affirming hormone therapy

  • Not approved for heart disease or dementia prevention

Bijuve

Bijuve is FDA-approved to treat moderate to severe hot flashes caused by menopause in women who still have a uterus. It pairs estrogen with progesterone in a single capsule so a separate progestogen is not needed. It is not approved for women without a uterus or for preventing heart disease, stroke, or dementia.

  • FDA-approved for moderate to severe menopausal hot flashes

  • Only approved for women with a uterus

  • Progesterone included, so no separate progestogen needed

  • Not approved for women without a uterus

Divigel vs. Bijuve Pros and Cons

Divigel

Divigel has the longest track record of any estrogen gel here, having been FDA-approved since 1975, and its four dose strengths allow for fine-tuned titration. As a topical gel, it avoids first-pass liver metabolism, which some studies suggest may lower clotting risk compared with oral estrogen. Because it lacks progesterone, it typically costs more overall once a companion progestogen prescription is added for women with a uterus.

Pros

  • Four dose strengths allow gradual, individualized titration

  • Topical application avoids first-pass liver metabolism

  • FDA-approved since 1975, longest history of the two

  • Can be paired with any progestogen, not locked to one formulation

Cons

  • Requires a separate progestogen for women with a uterus

  • Risk of transferring estrogen to others through skin contact

  • Daily gel application is less discreet than a capsule

  • Roughly $650 to $900 per month without insurance, pricier than Bijuve

Bijuve

Bijuve is the only FDA-approved capsule that combines bioidentical estradiol and micronized progesterone in a single daily dose, simplifying treatment for women with a uterus. Because progesterone is already built in, there is no need to coordinate a second prescription or separate dosing schedule. Its oral form and two fixed-dose strengths keep dosing simple but leave less room for gradual adjustment.

Pros

  • Combines estrogen and progesterone in one daily capsule

  • No separate progestogen prescription needed

  • No skin-contact transfer risk since it is swallowed

  • Roughly $257 to $351 per month without insurance, less than Divigel

Cons

  • Only two fixed-dose strengths, less room for fine titration

  • Not approved for women without a uterus

  • Oral form undergoes first-pass liver metabolism

  • Higher reported rate of breast tenderness, up to 10.4%

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.